Announced
Financials
Tags
United States
pharmaceutical company
Pharmaceuticals
Domestic
Friendly
Majority
Public
clinical stage biotechnology
Acquisition
Single Bidder
Pending
Synopsis
AbbVie, an American pharmaceutical company, agreed to acquire Landos Biopharma, a clinical stage biopharmaceutical company, for $212m. "With this acquisition, we aim to advance the clinical development of NX-13, a differentiated, first-in-class, oral asset with the potential to make a difference in the lives of people living with ulcerative colitis and Crohn’s disease,” Roopal Thakkar, AbbVie senior vice president, chief medical officer, global therapeutics.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.